-
Managing locally advanced or metastatic breast cancer, after previous chemotherapy has failed.
-
As a part of combo therapy involving doxorubicin and cyclophosphamide, for operable node-positive breast cancer.
-
Controlling locally advanced or metastatic non-small cell lung cancer (NSCLC), after platinum-based therapy failure.
-
Working with cisplatin to manage NSCLC in patients who are new to chemotherapy.
-
Handling hormone-refractory metastatic prostate cancer, alongside prednisone.
-
Combating advanced gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, in conjunction with cisplatin and fluorouracil for previously untreated patients.
-
Managing locally advanced squamous cell carcinoma of the head and neck (SCCHN), in combination with cisplatin and fluorouracil as part of induction therapy.
DOCETERE 20
MRP | : |
|
Price | : | ₹1,150.00 |
You Save | : | ₹1,861.63 (61.81%) |
Pack of 1 Units
Docetere 20 MG Injection 1 is primarily utilised to manage various types of cancer. This prescription medication belongs to the class of chemotherapy medicines known as taxanes.
In addition to its principal use, this medication can also be used to manage locally advanced or metastatic breast cancer, non-small cell lung cancer (NSCLC), metastatic prostate cancer, advanced gastric adenocarcinoma, and locally advanced squamous cell carcinoma of the head and neck (SCCHN). It can be used as a single agent in certain cases or in combination with other medicines depending on the type and stage of the cancer.
It’s crucial that you administer this injection exactly as recommended by your doctor. Prior to initiating this medicine, inform your doctor about any ongoing medications or pre-existing conditions you might have. If you experience any side effects while on this medication, report them to your doctor immediately. For optimal results, continue using the medicine for the full duration prescribed by your doctor.